Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.
Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback